Access Vascular announced today that it has successfully raised $22 million in a Series C financing round. The funding round saw participation from both new and returning investors. Billerica, Massachusetts–based AVI said the funds will significantly boost production capacity for its Mimix hydrophilic biomaterial vascular access devices. … [Read more...] about Access Vascular raises $22 million for production expansion
Access Vascular
Access Vascular’s HydroPICC shows positive results in reducing clot formation and failures
Access Vascular this week announced positive results from a study of its HydroPICC catheter. Billerica, Massachusetts-based Access Vascular designed the device to help reduce the most common and costly complications that are associated with vascular access procedures, including infection, thrombosis and phlebitis. The HydroPICC is constructed of … [Read more...] about Access Vascular’s HydroPICC shows positive results in reducing clot formation and failures
Access Vascular wins FDA clearance for HydroPICC catheter
Access Vascular this week received FDA clearance for its second-generation HydroPICC peripherally inserted central catheter. The HydroPICC has demonstrated thrombus accumulation rate 30 times less than traditional peripherally inserted central catheters (PICC), according to the company. PICCs can help reduce the risk of catheter occlusions … [Read more...] about Access Vascular wins FDA clearance for HydroPICC catheter
